Excretion into breast milk is insignificant and safe for pediatric treatment. Since the possibility of harmful effects on the blood and kidney among treated patients is controversial (not through breast milk) high dosing would better be avoided within 21 days post delivery. Keratolac eye drops are very safe because a low content of drug. The American Academy of Pediatrics rates it usually compatible with breastfeeding.